Strata Skin Sciences, Inc. (NASDAQ:SSKN) is reporting second quarter earnings results on Tuesday 11th August 2020, before market open.
The consensus estimates from Thomson Reuters are loss of $ 0.03 per share from $ 5.13 million in revenue.
For the full year, analysts predict revenues of $ 25.56 million, while looking forward to loss of $ 0.13 per share.
Previous Quarter Performance
Strata Skin Sciences, Inc. unwinded loss for the first quarter of $ 0.03 per share, from the revenue of $ 6.73 million. The quarterly revenues compared with the same quarter last year. Wall street analysts are predicting, SSKN to report 1Q20 loss of $ 0.05 per share from revenue of $ 5.87 million. The bottom line results beat street analysts by $ 0.02 or 40.00 percent, at the same time, top line results outshined analysts by $ 0.86 million or 14.65 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Strata Skin Sciences, Inc.
Stock Performance
According to the previous trading day, closing price of SSKN was $ 1.30, representing a 73.33 % increase from the 52 week low of $ 0.75 and a 54.39 % decrease over the 52 week high of $ 2.85.
The company has a market capital of $ 43.83 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”SSKN” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
Strata Skin Sciences, Inc. will be hosting a conference call at 8:30 AM eastern time on 11th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.strataskinsciences.com
STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.
